Artwork
iconShare
 
Manage episode 516750564 series 3698739
Content provided by American University of Beirut. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American University of Beirut or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this compelling episode, we delve into a quiet revolution happening in Lebanon that’s sending ripples across the global oncology community. Dr. Ali Bazarbachi, a physician-scientist at the American University of Beirut (AUB), has dedicated his career to tackling adult T-cell leukemia/lymphoma (ATL)—a rare and deadly blood cancer once deemed incurable.

Through decades of research, Dr. Bazarbachi has upended longstanding beliefs about the disease and pioneered a new treatment strategy targeting the HTLV-1 virus responsible for ATL. His innovative work has quadrupled survival rates and now, with a novel triple therapy, is showing potential for a cure.

Are you a member of the media looking to speak with an AUB expert on this topic or others? Please email [email protected]​​.

Interested in getting stories like this in your inbox? Subscribe to our monthly newsletter! To see more stories like these, click here!​​​​

  continue reading

13 episodes